Suntech’s bond default crisis worries dim sum bond investors; Global Bio-Chem Technology Group recently failed to honor its liability for bonds issued in Hong Kong following a technical issue

Suntech’s crisis worries dim sum bond investors

Staff Reporter, 2013-04-19

The ongoing reorganization of the debt-ridden Chinese solar power company Suntech could have an adverse effect on the Hong Kong dim sum bond market, Guangzhou’s 21st Century Business Herald reports.

The dim sum bond market refers to an offshore debt capital market for bonds denominated in the Chinese currency, the renminbi.

Many investors are increasingly concerned that Suntech’s financial troubles could signal a downward trend that may also hit the issuers of their bond investments.

The biotechnology company Global Bio-Chem Technology Group recently failed to honor its liability for bonds issued in Hong Kong following a technical issue. Though the company’s assets redeemed its bonds and avoided a domino effect in the market, many investors still fear the worst.Foreign investors have been reluctant to invest in dim sum bonds due to their lack of international ratings, the non-transparency of the issuers’ financial abilities, and their poor liquidity. Instead preferring to buy bonds issued by foreign companies or by the Chinese government, and shy away from bonds issued by Chinese companies, according to the 21st Century Business Herald.

A market analyst cited in the paper said dim sum bonds were initially launched to absorb the large quantity of overseas renminbi, but as there are now severals ways to channel the renminbi reserves back to China, the bonds have lost their appeal.

The attraction of the bonds depend largely on the credit of their issuers, therefore Suntech’s current circumstances could further dampen investors’ interest in the dim sum market, he added.

Unknown's avatarAbout bambooinnovator
Kee Koon Boon (“KB”) is the co-founder and director of HERO Investment Management which provides specialized fund management and investment advisory services to the ARCHEA Asia HERO Innovators Fund (www.heroinnovator.com), the only Asian SMID-cap tech-focused fund in the industry. KB is an internationally featured investor rooted in the principles of value investing for over a decade as a fund manager and analyst in the Asian capital markets who started his career at a boutique hedge fund in Singapore where he was with the firm since 2002 and was also part of the core investment committee in significantly outperforming the index in the 10-year-plus-old flagship Asian fund. He was also the portfolio manager for Asia-Pacific equities at Korea’s largest mutual fund company. Prior to setting up the H.E.R.O. Innovators Fund, KB was the Chief Investment Officer & CEO of a Singapore Registered Fund Management Company (RFMC) where he is responsible for listed Asian equity investments. KB had taught accounting at the Singapore Management University (SMU) as a faculty member and also pioneered the 15-week course on Accounting Fraud in Asia as an official module at SMU. KB remains grateful and honored to be invited by Singapore’s financial regulator Monetary Authority of Singapore (MAS) to present to their top management team about implementing a world’s first fact-based forward-looking fraud detection framework to bring about benefits for the capital markets in Singapore and for the public and investment community. KB also served the community in sharing his insights in writing articles about value investing and corporate governance in the media that include Business Times, Straits Times, Jakarta Post, Manual of Ideas, Investopedia, TedXWallStreet. He had also presented in top investment, banking and finance conferences in America, Italy, Sydney, Cape Town, HK, China. He has trained CEOs, entrepreneurs, CFOs, management executives in business strategy & business model innovation in Singapore, HK and China.

Leave a comment